Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | TNK2 | Q07912 | 3/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPY1R | P25929 | 1/20 | 0.35 |
| ▸ | NPY2R | P49146 | 1/20 | 0.35 |
| ▸ | NPY4R | P50391 | 1/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15093959 | 1.00 | MEN1 (0.43) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL15093765 | 1.00 | MEN1 (0.43) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL217929 | 0.95 | TNK2 (0.43) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL7155013 | 0.95 | ALDH1A1 (0.41) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL15214980 | 0.95 | ALDH1A1 (0.41) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL15214979 | 0.95 | ALDH1A1 (0.41) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL16055037 | 0.92 | HSD11B1 (0.41) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL21400657 | 0.91 | APP (0.44) | MEN1KMT2AHSD11B1TNK2PTPN1 | |
| SCHEMBL3500438 | 0.91 | TNK2 (0.44) | MEN1KMT2AHSD11B1TNK2DHFR | |
| SCHEMBL28981248 | 0.89 | CALM1 (0.41) | MEN1KMT2AHSD11B1TNK2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118750401-A | Composition for improving mitochondrial function, care product and application | 深圳市护家科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| WO-2024165901-A1 | BENZO[b]SELENOPHENES AS NOVEL SELECTIVE ESTROGEN RECEPTOR MODULATORS | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2024-08-15 | — | — | WO | claimed |
| EP-3335694-B1 | MELANOGENESIS INHIBITOR | TAKASAGO PERFUMERY CO LTD (JP) | 2023-09-27 | — | — | EP | claimed |
| CN-112121223-B | Sericin medical dressing and production method thereof | 河南民兴生物科技股份有限公司 | 2022-05-20 | — | — | CN | claimed |
| WO-2022092639-A1 | STABILIZATION COMPOSITION INCLUDING HYDROQUINONE OR DERIVATIVE THEREOF | 주식회사 엘지생활건강 | 2022-05-05 | — | — | WO | claimed |
| CN-114425024-A | Stabilized compositions containing hydroquinone or derivatives thereof | 株式会社LG生活健康 | 2022-05-03 | — | — | CN | claimed |
| EP-3212688-B1 | THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES | LUBRIZOL ADVANCED MAT INC (US) | 2022-04-13 | — | — | EP | claimed |
| US-9708287-B2 | Chiral compounds, compositions, products and methods employing same | CAYMAN CHEMICAL COMPANY INCORPORATED (US) | 2017-07-18 | — | — | US | claimed |
| US-9180080-B2 | Chiral compounds, compositions, products and methods employing same | MERZ NORTH AMERICA, INC. (US) | 2015-11-10 | — | — | US | claimed |
| EP-2800470-A1 | SKIN LIGHTENING COMPOSITIONS | Merz North America, Inc. (US) | 2014-11-12 | — | — | EP | claimed |
| US-20130224137-A1 | SKIN LIGHTENING COMPOSITIONS | LASYA, INC. (US) | 2013-08-29 | — | — | US | claimed |
| WO-2013103874-A1 | SKIN LIGHTENING COMPOSITIONS | LASYA, INC. (US) | 2013-07-11 | — | — | WO | claimed |
| EP-0748307-B1 | SKIN LIGHTENING COMPOSITIONS | PROCTER & GAMBLE (US) | 2001-12-12 | — | — | EP | claimed |
| US-6068834-A | ORALLY ADMINISTERING A MELANINS REDUCING OXY PHENOL COMPOUND TO THE MAMMAL FOR LIGHTENING THE MAMMALIAN SKIN; TYROSINASE INHIBITOR | THE PROCTER & GAMBLE COMPANY (US) | 2000-05-30 | — | — | US | claimed |
| EP-0748307-A1 | SKIN LIGHTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-18 | — | — | EP | claimed |
| WO-1995023780-A2 | SKIN LIGHTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-09-08 | — | — | WO | claimed |
| JP-6192062-A | — | — | None | — | — | JP | disclosed |
| WO-2026104315-A1 | TOPICAL SKIN CARE COMPOSITIONS WITH C16:1 FATTY ACID | UNILEVER IP HOLDINGS B.V. (NL) | 2026-05-21 | — | — | WO | disclosed |
| JP-H06192062-A | DERMAL EXTERNAL PREPARATION | SHISEIDO CO LTD | 1994-07-12 | — | — | JP | disclosed |
| EP-0383319-A2 | Imidazopyridines, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1990-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130224137-A1 | SKIN LIGHTENING COMPOSITIONS | CUTA, COL14A1, COLGALT1 | MEN1 3556/4885KMT2A 4262/4885HSD11B1 1544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.